BiotechTube
Home/Carisma Therapeutics/Michael Klichinsky
MK

Michael Klichinsky

Co-Founder & Chief Scientific Officer

Carisma Therapeutics

Therapeutic Areas

OncologyFibrosisAutoimmune Disease

Carisma Therapeutics Pipeline

DrugIndicationPhase
CT-0508HER2-Overexpressing Solid TumorsPhase 1
CT-0525HER2-Positive Solid TumorsPreclinical
In Vivo CAR-MUndisclosed Oncology TargetsDiscovery
CT-1119GPC3+ Solid TumorsDiscovery/Preclinical
CT-2401Liver FibrosisDiscovery/Preclinical
Autoimmune Disease ProgramAutoimmune DiseaseDiscovery

Leadership Team at Carisma Therapeutics

SK
Steven Kelly
President & Chief Executive Officer
SZ
Sanford Zweifach
Chairman of the Board
JH
John Hohneker
Board Member
BM
Briggs Morrison
Board Member
DS
David Scadden
Board Member
View full Carisma Therapeutics profile